...
机译:光活化小分子微管靶向剂的开发和生物学评价
School of Medical Sciences and Charles Perkins Centre The University of Sydney Sydney NSW 2006 Australia;
School of Medical Sciences and Charles Perkins Centre The University of Sydney Sydney NSW 2006 Australia;
School of Medical Sciences and Charles Perkins Centre The University of Sydney Sydney NSW 2006 Australia;
QIMR Berghofer Medical Research Institute 300 Herston Road Herston QLD 4006 Australia;
QIMR Berghofer Medical Research Institute 300 Herston Road Herston QLD 4006 Australia;
Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative Centre for Cancer Research Hudson Institute of Medical Research 27-31 Wright Street Clayton VIC 3168 Australia;
Institute of Pharmacy Christian-Albrechts-University of Kiel Gutenbergstra?e 76 24118 Kiel Germany;
Institute of Pharmacy Christian-Albrechts-University of Kiel Gutenbergstra?e 76 24118 Kiel Germany;
School of Medical Sciences and Charles Perkins Centre The University of Sydney Sydney NSW 2006 Australia;
glioblastoma; Photoactivatable caged prodrug; tubulin inhibitor;
机译:光活化小分子微管靶向剂的开发和生物学评价
机译:新型微管靶向剂1-亚苄基-3,4-二氢萘-2-一的合成及生物学评价
机译:一种有效的微管靶向剂的发现:康普他汀A-4衍生物的水溶性氨基酸前药的合成和生物学评估
机译:单分子成像的光活化荧光蛋白开发。
机译:设计,合成和新型的基于紫杉醇的小分子治疗性PET / SPECT成像剂和纳米级不对称领结树枝状大分子药物偶联物针对肿瘤靶向化疗的生物学评估。
机译:光活化的发展和生物学评估小分子微管靶向剂
机译:返回盖子:作为微管靶向剂的咪唑吡啶 - 氧杂交缀合物的合成和生物学评价(ChemMedchem 12/2013)
机译:评估候选生物控制剂安全性的指南